Standard whole blood composition for determining the potency of

Details Standard whole blood composition for determining the potency of Standard whole blood composition for determining the potency of

1993-01-14

1994-06-07

Housel, James C.

Chemistry: analytical and immunological testing

Composition for standardization, calibration, simulation,...

430 11, 430 16, 430 63, 430 69, G01N 3100

Patent

active

053189108

ABSTRACT:
A standard whole blood composition is disclosed, which is useful as a pooled human hemostasis reference standard in blood coagulation assays including Activated Clotting Time (ACT), Whole Blood Prothrombin Time (WBPT), Whole Blood Activated Partial Thromboplastin Time (WBAPTT) and Whole Blood Thrombin time (WBTT). Also disclosed are methods for determining the human standardized potency of heparin and protamine.

REFERENCES:
patent: 4250041 (1981-02-01), Babson et al.
patent: 4489162 (1984-12-01), Hankins et al.
patent: 4731330 (1988-03-01), Hill et al.
patent: 4871677 (1989-09-01), Baugh et al.

Affiliated with

Also associated with

Rating

Standard whole blood composition for determining the potency of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Standard whole blood composition for determining the potency of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Standard whole blood composition for determining the potency of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-792357